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Abstract. Pancreatic cancer is the fourth leading cause of 
cancer-associated mortality. The major risk factor for pancreatic 
cancer is cigarette smoking. Kras mutations are commonly 
observed in human pancreatic cancers. The present study 
examined the hypothesis that exposure to cigarette smoke and 
overexpression of a mutant Kras gene in the pancreas affects 
pancreatic cell proliferation in mice. Mice overexpressing the 
mutant Kras gene (KRasG12D) in the pancreas as well as wild-type 
mice were exposed to environmental tobacco smoke for 2 weeks. 
Overexpression of mutant Kras increased cell proliferation in 
pancreatic ductal, acinar and islet cells. Notably, cigarette smoke 
exposure decreased cell proliferation in pancreatic ductal and 
acinar cells, and had no effect in islet cells. Cigarette smoke 
did not affect pancreatic protein levels of tumor necrosis factor 
(TNF)α, p53, or cyclin D1, but mutant Kras overexpression 
slightly decreased TNFα and p53 protein levels. Therefore, 
pancreatic cell proliferation in mice overexpressing mutant Kras 
is associated with the later development of pancreatic tumors, 
but effects of cigarette smoke on pancreatic cell proliferation do 
not provide a good model for human pancreatic carcinogenesis. 
Introduction
Pancreatic cancer is the tenth most common form of cancer, and 
is the fourth leading cause of cancer-associated mortality (1). 
Pancreatic cancer is one of the deadliest forms of cancer, with a 
5-year survival rate of only 4.4%.
A number of risk factors have been identified for pancre-
atic cancer, including gender, ethnicity and history of chronic 
pancreatitis (2). The greatest environmental risk factor for 
pancreatic cancer is cigarette smoking (2). The relative risk for 
cigarette smoking is between 2 and 3 fold, but can be higher in 
heavy smokers, suggesting a dose-response association (2). It is 
not clear how cigarette smoke contributes to pancreatic cancer 
development. Components of cigarette smoke likely reach the 
pancreas through the general circulation, but also may come 
from the GI tract through reflux. The chemical component(s) of 
cigarette smoke that are responsible for increasing pancreatic 
cancer risk are not known, although some evidence supports 
a role for aromatic amines or N-nitroso compounds (2). The 
molecular mechanisms of the enhancement of pancreatic cancer 
by cigarette smoke are not understood.
One approach to understanding the molecular mecha-
nisms of pancreatic cancer development is to use animal 
models. Several chemical carcinogenesis models exist (3). 
A transgenic model has been developed, which uses 
an oncogenic Kras (KRasG12D) inserted into the endog-
enous Kras locus (4). The gene has a Lox-STOP-Lox (LSL) 
construct inserted upstream. These mice are interbred with 
mice containing the Cre recombinase downstream from 
a pancreatic specific promoter, either PDX‑1 or P48. The 
PDX‑1‑Cre;LSL‑KRasG12D mice develop pancreatic intraepi-
thelial neoplasias (PanINs), which progress over time (4). In 
addition, when these mice are crossed to mice containing p53 
mutations or Ink4a/Arf deficiency, the rapid development of 
pancreatic adenocarcinomas is observed (5,6).
The present study examined the hypothesis that exposure 
to cigarette smoke or overexpression of the oncogenic Kras 
oncogene would affect cell proliferation in the pancreas in mice. 
PDX‑1‑Cre; LSL‑KRasG12D and wild-type mice were exposed to 
cigarette smoke for 2 weeks. It has been observed previously that 
a 5‑day exposure to cigarette smoke is sufficient to increase cell 
proliferation in the lung (7,8). Mice were treated with bromo-
deoxyuridine (BrdU) during the exposure period, and the rate 
of cell proliferation and gene expression associated with cell 
proliferation were examined.
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Materials and methods
Experimental design. PDX‑1‑Cre and LSL‑KRASG12D mice were 
obtained from the National Cancer Institute Mouse Repository 
(Frederick, MD, USA). The two strains were bred to obtain 16 
PDX‑1‑Cre; LSL‑KRASG12D mice. PDX‑1‑Cre‑positive mice 
were used as controls. Male 9-10 week old mice were used. 
Half of the mice in each group were exposed to cigarette smoke 
for a period of 2 weeks. In total, 7‑8 mice were in each of the 
4 groups, with a total of 30 mice. An inhalation exposure to 
smoke was performed in a whole-body Hinners type stain-
less steel/glass chamber, as previously described (9). Cigarette 
smoke was generated from 3R4F University of Kentucky 
(Lexington, KY, USA) research cigarettes. The concentration of 
smoke particulates in the exposure chamber atmosphere aver-
aged 46±3 mg TPM/m3. The mice received smoke exposure for 
a total of 6 h each day, 5 days per week, Monday to Friday, for 
2 weeks (10 days total exposure). Mice were euthanized 3 days 
after the last exposure (the next Monday morning). Mice were 
administered BrdU in the drinking water (0.5 mg/ml), starting 
at the same time as smoke exposure, and continuing until they 
were euthanized. Subsequently, the pancreas was split into two 
pieces, with one half fixed in buffered neutral formalin (and 
subsequently processed to paraffin blocks) and the other half 
flash frozen in liquid nitrogen, and then stored at ‑80˚C.
Analysis of cell proliferation. Subsequent to fixation and 
processing, 5-µm sections were prepared from the paraffin 
blocks. The sections of paraffin‑embedded tissue samples were 
deparaffinized, thoroughly washed in water, and then placed 
in 3% H2O2 in methanol for 10 min. The sections were then 
stained immunohistochemically by the avidin-biotin-perox-
idase complex method using Vectastain ABC reagent (Vector 
Laboratories, Burlingame, CA, USA), with mouse anti-BrdU 
monoclonal antibodies (cat. no. 555627; BD Biosciences, 
Franklin Lakes, NJ, USA), at 100 µl/slide using a 1:40 dilution 
of BrdU. The reaction product was then visualized using diami-
nobenzidine (Vector Laboratories Peroxidase Substrate kit) and 
the slides were counterstained with hematoxylin. Having brown 
nuclei identified cells that had incorporated BrdU. Labeling 
indexes were determined for the following 3 regions in the 
pancreas: ductal, acinar and islet cells. In total, 500 cells per 
slide were counted and labeling indexes were determined.
Western blot analysis. Levels of tumor necrosis factor (TNF) 
a, p53 and cyclin D1 proteins in pancreas homogenates were 
determined by western analyses. Antibodies were obtained 
from Santa Cruz Biotechnology (Dallas, TX, USA). The frozen 
pancreases were homogenized in extraction buffer (Pierce 
Biotechnology, Inc., Rockford, IL, USA) containing protease 
inhibitors (Sigma‑Aldrich; Merck Millipore, Darmstadt, 
Germany). Lysed tissue was centrifuged at 8,000 x g for 30 min 
at 4˚C. Protein levels of the supernatants were determined by 
bicinchoninic acid assay (Pierce Biotechnology, Inc.) and stored 
at ‑80˚C. Protein samples (30 µg per treatment) were separated 
using 10% SDS-PAGE and subsequently were transferred onto 
nitrocellulose membranes. Membranes were blocked with 5% 
non‑fat milk buffer and incubated overnight at 4˚C with primary 
antibodies. Subsequent to washing, membranes were incu-
bated with secondary antibodies conjugated with horseradish 
peroxidase and visualized using enhanced chemiluminescence 
detection reagents (Thermo Fisher Scientific Inc., Waltham, MA, 
USA). Bands were quantified using ImageJ software (National 
Institutes of Health, Bethesda, MD, USA) and normalized to 
β-actin expression.
Statistical analysis. Results were first analyzed by two‑way 
analysis of variance (ANOVA), using Sigmaplot for Windows 
(version 13.0; Systat Software, Inc., San Jose, CA). If significant 
interactions were identified, differences between means were 
determined using the Holm-Sidak post-hoc test. The results are 
reported as the mean ± standard error of the mean. P≤0.05 was 
considered to indicate a statistically significant difference. The 
results of the ANOVAs are shown in Table I.
Results
The present study examined the effects of mutant Kras 
overexpression and smoke exposure on pancreatic cell prolif-
eration and associated gene expression. Mice were exposed to 
sidestream tobacco smoke for 2 weeks. Mutant Kras overex-
pression did not affect body weights, but short-term cigarette 
Table I. Results of two-way analysis of variance for the study endpoints.
 P-values
 ------------------------------------------------------------------------------------------------------------------------------------------------------------------
Study Main effect for Main effect for Smoke/Kras
endpoint smoke exposurea Kras overexpressionb interaction
Final body weight  0.033 0.41 0.27
Ductal cell LI  0.016 <0.001 0.12
Acinar cell LI  0.013 <0.001 0.28
Islet cell LI 0.72 <0.001   0.066
TNFα 0.58 0.10 0.84
P53 0.59   0.090 0.75
Cyclin D1 0.39 0.38 0.89
avs. non‑smoke exposure group; bvs. wild‑type Kras expression group. LI, labeling index; TNF, tumor necrosis factor.
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smoke exposure significantly reduced body weights (P=0.033; 
data not shown). Mice were administered BrdU in the drinking 
water, and then labeling indexes of BrdU-stained nuclei were 
used to quantify cell proliferation. Cell proliferation in ductal 
Figure 1. Labeling indices in pancreatic (A) ductal, (B) acinar and (C) islet cells. Results are expressed as the mean ± standard error, with n=7 or 8. *Significant 
differences due to mutant Kras overexpression are indicated with an asterisk; ^significant differences in smoke‑exposed mice (P<0.05). Cre, Cre recombinase.
Figure 2. (A) The western blot analysis shows expression of TNF-α, p53, cyclin D1 and β-actin in pancreas tissue lysates (A). The graphs show quantitative 
analysis of protein expression for (B) TNF-α, (C) p53, and (D) cyclin D1 using ImageJ. β-actin was used as the loading control. Results are expressed as the 
mean ± standard error, with n=3 or 4. TNF‑α, tumor necrosis factor α; R, Kras; C/Cre, Cre recombinase; AU, arbitrary unit.
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cells, from which the majority of human pancreatic cancers 
are derived, was increased (P<0.001) in mice overexpressing 
mutant Kras; however, cigarette smoke exposure decreased 
(P=0.016) cell proliferation (Fig. 1). In acinar cells, cell 
proliferation was similarly increased (P<0.001) by mutant 
Kras overexpression and decreased (P=0.013) by cigarette 
smoke exposure. In islet cells, cell proliferation was increased 
(P<0.001) by mutant Kras overexpression, but not affected by 
cigarette smoke exposure.
Subsequently, the levels of several proteins in the pancreas 
that could be affecting cell proliferation and tumorigenesis 
were examined. TNFα is a pro‑inflammatory cytokine that 
may have promoting or inhibitory effects in pancreatic carci-
nogenesis (10). p53 is a tumor suppressor gene that promotes 
apoptosis but also inhibits cell proliferation (11). Cyclin D1 
regulates cyclin-dependent kinases (CDKs), which increase 
cell proliferation (12). Neither cigarette smoke exposure nor 
Kras overexpression, however, significantly affected the protein 
levels of TNFα, p53, or cyclin D1 in the pancreas (Fig. 2). Kras 
overexpression slightly, but not significantly, decreased the 
protein levels of TNFα (P=0.10) and p53 (P=0.09).
Discussion
In the present study, it was observed that Kras overexpression 
increased but cigarette smoke exposure decreased cell prolif-
eration in pancreatic ductal cells, the cell type from which 
most human pancreatic cancers are derived. It was observed 
that cigarette smoke induced decreases in cell proliferation in 
pancreatic ductal cells and acinar cells but had no effect in 
islet cells. A previous study has quantified cell proliferation in 
response to cigarette smoke; Wisniewska et al (13) observed 
inconsistent effects of cigarette smoke. Wisniewska et al (13), 
however, did not differentiate between the different types of 
pancreatic cells. Cigarette smoke was found not to promote 
7,12-dimethylbenzanthracene-induced pancreatic carcino-
genesis in mice (14). Cell proliferation was increased in the 
lung after short-term exposure to cigarette smoke in several 
studies (7,8,15,16). In other studies examining cell prolifera-
tion in the pancreas, Xue et al (17) found that diets high in fat 
and phosphorus and low in calcium and vitamin D increased 
cell proliferation in pancreatic ductal and acinar cells. 
Ledda-Columbano et al (18) found that the administration 
of thyroid hormone increased cell proliferation in pancreatic 
acinar cells.
The present study observed that the expression of a mutant 
Kras oncogene in the pancreas increased cell proliferation in 
ductal, acinar and islet cells. The expression of this oncogene 
has previously been shown to induce PanINs and pancreatic 
tumors (4). The expression of the mutant Kras produces 
metabolic changes that are supportive of an increase in cell 
proliferation (19).
Neither KrasG12D nor smoke exposure significantly affected 
the levels of three proteins that could affect cell proliferation. 
One factor could have been that whole pancreas was used in 
the analysis, which could have prevented the observation of 
changes in individual cell types. KrasG12D's inhibitory effect 
on p53 protein levels is consistent with the effect of p53 on 
increasing apoptosis but inhibiting cell proliferation (11). TNFα 
has been found to increase pancreatic cell proliferation (20,21); 
therefore, it is not clear how Kras inhibition of TNFα contrib-
utes to the increase in cell proliferation observed in the mutant 
Kras mice.
In summary, the present mouse model does not appear to be 
a good model for cigarette smoke-induced human pancreatic 
carcinogenesis. Cigarette smoking is the number one environ-
mental risk factor for human pancreatic cancer. Therefore, the 
inhibition of pancreatic ductal and acinar cell proliferation 
by smoke exposure in the present study is not associated with 
smoke effects on humans. It would be expected that decreased 
cell proliferation would be protective against pancreatic carci-
nogenesis.
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